Outcome of Transurethral Plasmakinetic Vaporization for Benign Prostatic Hyperplasia

PURPOSE: To assess the outcome of transurethral plasmakinetic vaporization (PKVP) in the management of benign prostatic hyperplasia (BPH). PATIENTS AND METHODS: From August 2010 to May 2012, 60 patients with obstructive LUTS due to BPH were included in the study. All patients were evaluated by Inter...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Tabey, Magdy, Abo-Taleb, Ahmed, Abdelal, Ashraf, Khalil, Mostafa Mahmod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752085/
https://www.ncbi.nlm.nih.gov/pubmed/26005964
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.02.08

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752085/
https://www.ncbi.nlm.nih.gov/pubmed/26005964
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.02.08

Ejemplares similares